Quantbot Technologies’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,298
Closed -$108K 2145
2026
Q1
$108K Buy
13,298
+13,130
+7,815% +$119K ﹤0.01% 1305
2025
Q4
$1.13K Buy
+168
New +$1.27K ﹤0.01% 1643
2023
Q2
Sell
-67,600
Closed -$468K 1840
2023
Q1
$468K Buy
67,600
+49,600
+276% +$456K 0.03% 626
2022
Q4
$185K Buy
+18,000
New +$318K 0.01% 926
2021
Q4
Sell
-2,115
Closed -$438K 1773
2021
Q3
$438K Buy
2,115
+1,578
+294% +$348K 0.03% 644
2021
Q2
$114K Buy
537
+315
+142% +$57.7K 0.01% 882
2021
Q1
$40K Buy
+222
New +$44.2K ﹤0.01% 1060
2020
Q3
Sell
-4,432
Closed -$369K 1533
2020
Q2
$369K Buy
+4,432
New +$170K 0.05% 296
2017
Q1
Sell
-23,113
Closed -$582K 1332
2016
Q4
$582K Buy
+23,113
New +$674K 0.06% 318
2015
Q4
Sell
-1,329
Closed -$187K 1283
2015
Q3
$187K Buy
+1,329
New +$298K 0.03% 545
2015
Q2
Sell
-672
Closed -$111K 1295
2015
Q1
$111K Buy
672
+662
+6,620% +$107K 0.03% 576
2014
Q4
$1K Buy
+10
New +$1.04K ﹤0.01% 1076

Other funds holding NVAX

Quantbot Technologies's NVAX Position: Q2 2026 in Review

Quantbot Technologies sold out of Novavax (NVAX) in Q2 2026, closing a stake of 13,298 shares — an estimated $108K sold.

Quantbot Technologies first reported a position in NVAX in Q4 2014 and held it in 12 quarters. The position peaked at $582K in Q4 2016. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Quantbot Technologies reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 13,298 Novavax shares in Q2 2026, an estimated $108K.
  • Quantbot Technologies first reported a position in Novavax in Q4 2014 and held it in 12 quarters.
  • Quantbot Technologies's Novavax position peaked at $582K in Q4 2016.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.